JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 11, 2003; DOI: 10.1124/jpet.103.054296


0022-3565/03/3072-745-752$20.00
JPET 307:745-752, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.054296v1
307/2/745    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaidyanathan, J. B.
Right arrow Articles by Walle, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaidyanathan, J. B.
Right arrow Articles by Walle, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Cellular Uptake and Efflux of the Tea Flavonoid (-)Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2

Jaya Bharathi Vaidyanathan, and Thomas Walle

Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina

(-)-Epicatechin gallate (ECG) is one of the flavonoids in green tea, which has been demonstrated to have cancer-preventive properties in many model systems. However, the extent and mechanisms of accumulation of these flavonoids in cells is unknown. The objectives of this study were to determine the accumulation of ECG by the intestinal epithelial cell Caco-2 and to characterize the transport mechanism involved. The cells were exposed to ECG ± various transport inhibitors and incubated at 37°C. Absorbed flavonoids were extracted and quantified by high-performance liquid chromatography. The uptake of ECG included a nonsaturable initial rapid process as well as a much slower saturable process. The saturable ECG uptake by the Caco-2 cells was sodium-independent but clearly dependent on a pH gradient. Phloretin and benzoic acid, inhibitors of the monocarboxylate transporter (MCT), significantly reduced ECG uptake. The uptake of ECG in the Caco-2 cells increased 2-fold in the presence of 50 µM 3-[{3-[2-(7-chloroquinolin-2-yl)vinyl]phenyl}-(2-dimethylcarbamoylethylsulfanyl)methylsulfanyl] propionic acid (MK-571), suggesting the involvement of multidrug-associated protein (MRP)2 in efflux of ECG. This was confirmed using Madin-Darby canine kidney cells transfected with MRP2. Also P-glycoprotein was responsible for some ECG efflux. MK-571 also caused a dramatic increase in ECG accumulation in Chinese hamster ovary cells, suggesting that ECG was also a substrate for MRP1. Together, these observations demonstrate important roles of membrane transporters, i.e., MCT, MRP2, P-glycoprotein, and MRP1, in the cellular accumulation and potential effects of ECG.


Received May 14, 2003; accepted July 10, 2003.

Address correspondence to: Dr. Thomas Walle, Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Ave., P.O. Box 250505, Charleston, SC 29425. E-mail: wallet{at}musc.edu




This article has been cited by other articles:


Home page
J. Nutr.Home page
S. M. Henning, J. J. Choo, and D. Heber
Nongallated Compared with Gallated Flavan-3-ols in Green and Black Tea Are More Bioavailable
J. Nutr., August 1, 2008; 138(8): 1529S - 1534S.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
R. Roohparvar, A. Huser, L.-H. Zwiers, and M. A. De Waard
Control of Mycosphaerella graminicola on Wheat Seedlings by Medical Drugs Known To Modulate the Activity of ATP-Binding Cassette Transporters
Appl. Envir. Microbiol., August 1, 2007; 73(15): 5011 - 5019.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Q. Wang and M. E. Morris
Flavonoids Modulate Monocarboxylate Transporter-1-Mediated Transport of {gamma}-Hydroxybutyrate in Vitro and in Vivo
Drug Metab. Dispos., February 1, 2007; 35(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. D. Lambert, S. Sang, J. Hong, S.-J. Kwon, M.-J. Lee, C.-T. Ho, and C. S. Yang
Peracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-Gallate
Drug Metab. Dispos., December 1, 2006; 34(12): 2111 - 2116.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. D. Lambert, M.-J. Lee, L. Diamond, J. Ju, J. Hong, M. Bose, H. L. Newmark, and C. S. Yang
DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
Drug Metab. Dispos., January 1, 2006; 34(1): 8 - 11.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. L. A. Sesink, I. C. W. Arts, V. C. J. de Boer, P. Breedveld, J. H. M. Schellens, P. C. H. Hollman, and F. G. M. Russel
Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Net Intestinal Uptake of Quercetin in Rats by Facilitating Apical Efflux of Glucuronides
Mol. Pharmacol., June 1, 2005; 67(6): 1999 - 2006.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. J. Baek, J.-S. Kim, F. R. Jackson, T. E. Eling, M. F. McEntee, and S.-H. Lee
Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells
Carcinogenesis, December 1, 2004; 25(12): 2425 - 2432.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.